儿童Stevens-Johnson综合征的慢性眼部后遗症:恰当治疗对疾病自然史的长期影响
该回顾性对比病例系列纳入1990至2015年间284例SJS患儿的568只眼,比较保守治疗(440眼)与确定性治疗(128眼)的长期视力结局。确定性治疗在5年随访时显著改善最佳矫正视力并阻止角膜病变发生或进展(P≤.002);睑缘相关角膜病变眼中,睑缘黏膜移植联合PROSE效果最佳(P<.0001)。
要点
- 三分之二患儿在急性SJS后一年以上才就诊,60%的眼存在低视力或盲。
- 8岁及以下患儿的眼部和视觉损害显著更重(P≤.037)。
- 睑缘相关角膜病变眼中,睑缘黏膜移植后PROSE联合效果最佳(P<.0001)。
核心结论
- 急性SJS期间未获恰当治疗的患儿后来出现严重的眼部和视觉损害。
- 及时治疗,尤其是睑缘相关角膜病变眼采用PROSE和睑缘黏膜移植,改变了自然病程并有助于保持和改善视力。
研究设计与样本
- 回顾性对比病例系列,纳入1990至2015年间284例SJS患儿的568只眼。
- 患眼接受保守治疗(440眼)或确定性治疗(128眼),后者包括睑缘黏膜移植、PROSE接触镜、同种异体角膜缘移植或角膜假体,依据干眼严重程度及角膜损伤原因和范围的算法选择。
- 主要结局指标为最佳矫正视力。
主要发现
- 三分之二患者在急性SJS后一年以上就诊,99%既往未行羊膜移植,60%的眼存在低视力或盲。
- 8岁及以下患儿的眼部和视觉损害显著更重(P≤.037)。
- 5年随访时,与保守治疗相比,确定性治疗显著改善最佳矫正视力并阻止角膜病变发生或进展(P≤.002)。
- 睑缘相关角膜病变眼中,睑缘黏膜移植显著优于PROSE,两者均显著优于保守治疗,睑缘黏膜移植后PROSE联合效果最佳(P<.0001)。
关键数值与推荐
- 确定性治疗较保守治疗在5年随访时改善最佳矫正视力并阻止角膜病变发生或进展(P≤.002)。
- 睑缘相关角膜病变眼中,睑缘黏膜移植与PROSE比较、两者分别与保守治疗比较以及联合方案比较,P<.0001。
临床怎么用
- 作者认为,及时治疗,尤其是睑缘相关角膜病变眼采用PROSE和睑缘黏膜移植,可改变自然病程并有助于保持和改善视力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe the long-term ocular and visual morbidity in children with chronic sequelae of Stevens-Johnson syndrome (SJS) and visual outcomes of various management strategies. DESIGN: Retrospective comparative case series. METHODS: This study included 568 eyes of 284 children with SJS who presented between 1990 and 2015. Affected eyes received either conservative therapy (n = 440) or definitive management (n = 128), including lid margin mucous membrane grafting (MMG), prosthetic replacement of the ocular surface ecosystem (PROSE) contact lenses, allogeneic limbal transplantation, or keratoprosthesis using an algorithmic approach based on the severity of dryness and cause and extent of corneal damage. The primary outcome measure was best-corrected visual acuity (BCVA). RESULTS: Two thirds of patients presented more than a year after acute SJS, 99% without prior amniotic membrane grafting, with low vision or blindness in 60% of eyes. Children 8 years or younger in age had significantly worse ocular and visual morbidity (P ≤ .037). At 5 years of follow-up, definitive therapy significantly altered the natural history of the disease by improving BCVA and preventing the development or progression of keratopathy, as compared to conservative therapy (P ≤ .002). In eyes with lid-related keratopathy, MMG was significantly more effective than PROSE, although both were significantly better than conservative therapy and the combination of MMG followed by PROSE provided the best results (P < .0001). CONCLUSION: Children receiving suboptimal care during acute SJS presented later with severe ocular and visual morbidity. Timely therapy, particularly with PROSE and MMG in eyes with lid-related keratopathy, changed the natural course and helped in preserving and improving vision.
引用
- Basu S, Shanbhag SS, Gokani A, et al. Chronic Ocular Sequelae of Stevens-Johnson Syndrome in Children: Long-term Impact of Appropriate Therapy on Natural History of Disease. Am J Ophthalmol. 2018. PMID: 29421293. doi:10.1016/j.ajo.2018.01.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。